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Abstract Of the 56 cysteines in the extracellular domain of the
CD18 antigen (L2 integrin subunit), corresponding ones are not
found in 12 positions in the L4, L7, or L8 integrin subunits. These
12 cysteines were mutated to alanines, either singly or in pairs, in
CD18. All these mutants can support the expression of all three
CD11/CD18 integrins. Transfectants expressing these variant
integrins are generally more adhesive than the wild-type,
suggesting that the cysteine residues, perhaps by engaging in
disulphide bonds, may contribute to the maintenance of the
CD11/CD18 integrins in a resting state. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The integrins are heterodimeric adhesion receptors formed
by the non-covalent association of an K and a L subunit, both
of which are type I membrane proteins [1,2]. Both the K and L
subunits are involved in ligand binding [2]. Using the L2 in-
tegrins as an experimental system, we aim to determine the
contribution of the L subunit in ligand binding and its regu-
lation. The extracellular domains of the L subunits are organ-
ised linearly, from the N-terminal, a PSI (plexin^semaphorin^
integrin) domain [3], a highly conserved region (HCR) with an
I-domain like structure [4^6], a mid-region and the major
cysteine-rich (CRR) region. Mutations in the HCR of the
L2 [7^10] and L3 subunits [11] had led to the expression of
integrins with no adhesion activities, suggesting that the HCR
may directly participate in ligand binding. The CRR, on the
other hand, may have a regulatory role. Deletion of the CRR
in the L2 [12] and L3 [13] subunit does not a¡ect the forma-
tion of the KLL2 and the KIIbL3 integrin, respectively. Fur-
thermore, these integrins were shown to be constitutively ac-
tive in ligand binding. It thus appears that the cysteine
residues of the integrin L subunits, particularly those in the
CRR, may have key roles in the regulation of integrin activa-
tion. We therefore mutated a set of cysteine residues in the L2
integrin subunit into alanines, and studied these mutants for
their ability to form functional leukocyte function-associated
antigen (LFA)-1 (KLL2, CD11a/CD18), Mac-1 (KML2,
CD11b/CD18), and p150,95 (KXL2, CD11c/CD18) integrins.
Alignment of the extracellular sequences of the eight human
L integrin subunits revealed 56 cysteine residues which are
absolutely conserved in the L1, L2, L3, L5, and L6 subunits
(Fig. 1). For convenient and universal reference, the cysteine
residues will be referred to as C1 to C56 from the N-terminal
end in this article. The other three L subunits lack the full
complement of the 56 cysteines: L4, L7, and L8 have 48, 54,
and 50 cysteines, respectively. The missing cysteines in these
subunits do not appear to be random since the same pairs of
cysteines are missing from two or more L subunits. C55 and
C56 are missing from L7. In addition to C55 and C56, L8 also
lacks C21, C22, C31, and C35. C31 and C35 are also missing
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Fig. 1. The putative domain organisation of the integrin L subunits.
The boundaries between di¡erent regions in the extracellular domain
must remain approximate since, to date, they have not been fully
characterised. The location of the 56 extracellular cysteines in the
L1, L2, L3, L5 and L6 subunits is marked by vertical lines under-
neath the main diagram. For convenient and universal reference of
the cysteine residues among the integrin L subunits, they are desig-
nated C1 and C56 from the N-terminal. The cysteine residues not
found in L4, L7, and L8 are shown in boxes. The locations of these
residues in the L2 subunit are shown underneath (the initiation me-
thionine residue assigned as residue 1). Cysteine residues missing in
L4, L7, and L8 are marked with crosses. TM, transmembrane seg-
ment; Cy, cytoplasmic segment.
*Corresponding author. Fax: (44)-1865-275729.
E-mail: alaw@molbiol.ox.ac.uk
1 These authors contributed equally to this work.
2 Present address: Microbiology and Immunology, University of
California, San Francisco, CA, USA.
3 Present address: Institute for Animal Health, Compton, Berks, UK.
4 Present address: Tenovus Research Laboratory, Southampton
General Hospital, Southampton, UK.
Abbreviations: mAb, monoclonal antibody; ICAM, intracellular ad-
hesion molecule; LFA, leukocyte function-associated antigen; HCR,
highly conserved region; CRR, cysteine-rich region
FEBS 24347 4-12-00
FEBS 24347 FEBS Letters 486 (2000) 89^92
from L4, whose other six missing cysteines are C8, C9, C12,
C13, C47, and C48. Since it is not possible to study the e¡ect
of all 56 cysteine residues at the same time, we decided to start
with this set of 12 cysteine residues, with the rationale that at
least some of them, because of their absence in other integrin
subunits, may not be absolutely required for the expression of
the L2 integrins.
2. Materials and methods
The monoclonal antibodies (mAbs) MHM24 (anti-KL), LPM19c
(anti-KM) and KB43 (anti-KX) were obtained as previously described
[10]. IB4 was purchased from ATCC. MEM48 was a gift from V.
Horejsi (Institute of Molecular Genetics, Prague, Czech Republic).
OX34 was a gift from M. Muklavec (Sir William Dunn School of
Pathology, Oxford, UK).
The KL, KM and KX cDNA expression clones, in pcDNA3 (Invi-
trogen BV, Groningen, The Netherlands), were described previously
[10,14]. The wild-type cDNA clone for the L2 integrin subunit was
described in Douglass et al. [15]. All cysteine to alanine mutations
were constructed using the strategy described by Horton et al. [16]
with standard molecular biology techniques. All constructed cDNA
clones were veri¢ed by sequencing.
COS-7 cells were transfected with the cDNA of various combina-
tions of K and L subunits of the CD11/CD18 integrins and studied for
their expression and adhesion to ligands with protocols described
previously [10,12]. Expression of the CD11/CD18 integrins was deter-
mined by £ow cytometry using the heterodimer speci¢c mAb IB4 [17].
MEM48 [18], at 10 Wg/ml, was added to promote adhesion.
3. Results
3.1. Expression of wild-type and variant LFA-1 on
COS-7 transfectants
Wild-type L2 cDNA, or L2 cDNAs with single or double
CCA substitution were co-transfected into COS-7 cells with
the wild-type KL cDNA. Surface expression of LFA-1 was
detected by £ow cytometry using the heterodimer speci¢c
mAb IB4. The results are shown in Fig. 2. In all cases,
LFA-1 expression was not signi¢cantly a¡ected by the
CCA mutations.
The transfectants were tested for their adhesion to immo-
bilised intracellular adhesion molecule (ICAM)-1 (Fig. 3).
Fig. 2. Expression of LFA-1 (CD11a/CD18 antigen or KLL2 integ-
rin) on COS-7 transfectants. Wild-type and mutant CD18 cDNA
were co-transfected into COS-7 cells with CD11a cDNA. Expression
of the LFA-1 was monitored by £ow cytometry using the mAb IB4
(solid lines). Background histograms (shaded) were obtained with ir-
relevant mAb OX34 of the same IgG2a isotype. Speci¢c expression
(shown in bold) is obtained by subtractive histogram analysis using
the CellQuest software (Becton Dickinson) from which % gated pos-
itive cells (%GP) and mean £uorescent intensity (MFI) of the posi-
tive population were also obtained. The expression index (EI) is cal-
culated as 100U(% positive cells)UMFI.
Fig. 3. Adhesion of COS-7 transfectants expressing wild-type LFA-1
and LFA-1 with single (upper panel) and double (lower panel)
CCA mutations to ICAM-1. Mutated cysteines are indicated by
the consensus cysteine numbering of integrin L subunits (see Fig. 1).
Experiments were performed in RPMI media without activating re-
agents (open bars), and in the presence of the activating mAb
MEM48 at 10 Wg/ml (shaded bars). Data shown in the upper panel
are obtained from a single representative experiment as are those
shown in the lower panel. Adhesion can be blocked with the anti-
KL mAb MHM24 (data not shown).
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Transfectants expressing wild-type LFA-1 adhered poorly to
ICAM-1 unless they were activated with the mAb MEM48.
LFA-1 with the single CCA mutations also supported adhe-
sion to ICAM-1 with a varying degree of e⁄ciency: the least
adhesive were the C8A and C9A variants, and the most adhe-
sive were the C31A and C35A variants. The double CCA
mutants showed, generally, a similar adhesion pro¢le to their
corresponding single CCA mutants. The adhesion of all
LFA-1 variants was promoted to a higher level with the acti-
vating mAb MEM48. The most active group, namely, those
with the single or double C31A and C35A mutations, were
least responsive.
3.2. Expression of wild-type and variant Mac-1 and p150,95 on
COS-7 transfectants
The six double CCA CD18 variants were also studied for
their support of Mac-1 and p150,95 expression (Fig. 4), and
adhesion to denatured BSA (Fig. 5). Similar results were ob-
tained as for LFA-1.
4. Discussion
The 56 cysteine residues, out of approximately 700 residues
in the extracellular domains of the integrin L subunits, are
arranged in a very characteristic pattern (see Fig. 1). Twelve
of these cysteines, however, are not absolutely conserved, and
can be grouped into six pairs. The importance of these cys-
teine residues in the L2 subunit was studied by mutation,
either singly or in pairs, into alanine residues. All L2 variants
with CCA mutations support the surface expression of LFA-
1. Transfectants expressing LFA-1 also showed varying de-
grees of adhesion to ICAM-1, and adhesion can be promoted
to a higher level with the activating mAb MEM48. The dou-
ble mutants were also analysed for their capacity to combine
with the KM and KX subunits. Transfectants were shown to
express Mac-1 and p150,95 and to adhere to denatured BSA.
Taken together, these results showed that these cysteine
residues are not required in the L2 integrin subunit for com-
bining with the KL, KM and KX subunits, and for supporting
the adhesion of the integrins to their respective ligands. On
more detailed examination of the data from repeated experi-
Fig. 4. Expression of Mac-1 (CD11b/CD18 antigen or KML2 integ-
rin) and p150,95 (CD11c/CD18 antigen or KXL2 integrin) on COS-7
transfectants. Wild-type and double CCA mutant CD18 cDNA
were co-transfected into COS-7 cells with CD11b (upper panel) or
CD11c (lower panel) cDNA. Expression of the Mac-1 and p150,95
antigens was monitored by £ow cytometry using the mAb IB4 as
described in Fig. 2.
Fig. 5. Adhesion of COS-7 transfectants expressing wild-type Mac-1
and p150,95 and the integrins with double CCA mutant CD18 to
denatured BSA. Details of the experiments are as in Fig. 3. Mac-1
and p150,95 adhesion can be blocked with the anti-KM mAb
LPM19c and anti-KX mAb KB43, respectively (data not shown).
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ments, a general trend may be observed: the mutants within
each pairing group behave similarly. Thus, the mutants in the
C8/C9 group are least e¡ective in supporting integrin hetero-
dimer expression, and expressed integrins are least adhesive to
ligands. Those in the C31/C35 group, on the other hand, are
the most adhesive, and adhesion to ligand is easily detected in
the absence of the activating mAb. It has been proposed that
when a pair of cysteines are missing in homologous proteins,
they may, when present, form a disulphide bond [19]. The
present results are consistent with the proposed pairs of cys-
teines being engaged in disulphide bonds, since the main e¡ect
of the mutations of either or both may be regarded as the
removal of the same disulphide bond. However, this cannot
be regarded as de¢nitive evidence.
A disulphide bonding model (Fig. 6) has been proposed for
the L3 integrin subunit [20]. Because the CRR is resistant to
proteolysis, disulphide bonds in the CRR were not determined
biochemically, but were assigned based on the assumptions
that there are four pseudo-repeating elements in the CRR
and the disulphide bonds are self-contained within each re-
peating unit. Four of the six pairs of cysteines addressed in
this work are also predicted to form disulphide bonds in this
model. They are C8^C9, C12^C13, C21^C22, and C47^C48.
The other two pairs, namely C31 and C35, and C55 and C56,
were not predicted to engage in disulphide bonds with each
other. If we apply this model to L4, L7, and L8, we are forced
to conclude that either there are unpaired cysteines in these
subunits, or their disulphide bonding patterns are di¡erent
from that of L3. Alternatively, the disulphide bond assign-
ments may have to be revised.
Previously, by replacing the CRR of the L2 subunit with
that from L1, we showed that the resultant chimeric integrin L
subunit combines with the KL subunit to form a LFA-1 that
is constitutively active in ICAM-1 adhesion [15]. Together
with the observations that many activating mAbs are mapped
to the CRR, we postulated that the CRR is important in
maintaining the integrin in its resting state. This is achieved
possibly by the interaction between di¡erent regions in the
CRR and/or their interaction with other regions of the integ-
rin heterodimer, both in the L and the K subunit. By introduc-
ing an incompatible region from another integrin L subunit,
or by the binding of an antibody, the normal interactions
between the di¡erent regions are perturbed resulting in the
release of the integrins into an active state. In the experiments
presented here, the mutants involved C12/C13, C21/C22, C31/
C35 and C55/C56 are more active than the wild-type L2. It is
possible that these cysteine residues, perhaps by way of engag-
ing in disulphide bonds, may contribute to the maintenance of
the L2 integrins in their resting state.
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Fig. 6. The disulphide bonding model of the integrin L subunits.
The model is based on the work of Calvette et al. [20]. The cysteine
residues are labelled by consensus numbering from C1 to C56 from
the N-terminal. Disulphide bonds are shown as solid lines between
the residues; indeterminable and alternative assignments are shown
as dashed lines. Cysteines missing in L4 are shown on black back-
ground, those missing in L7 on shaded background, and those miss-
ing in L8 are shown in square outlines.
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